SHP503-802
Completed
Drug Use Study With Intuniv® in European Countries
About this clinical trial
This study will evaluate and characterize people who are taking Intuniv, analyze prescribing behaviors of physicians, and determine whether Intuniv was correctly prescribed in Belgium, Denmark, Finland, Germany, Ireland, Netherlands, Norway, Spain, Sweden, and the United Kingdom.
DE
Observational clinical trial.
At a glance
What medical conditions were being studied?
Attention Deficit Hyperactivity Disorder (ADHD)
What was the clinical trial testing?
No Intervention
How many participants were enrolled?
5000
Were placebos part of the clinical trial?
No
When was the clinical trial conducted?
Nov 2018 - Apr 2022
How long was participation in the clinical trial?
Not applicable. Data collected will be checked every year for up to 4 years.
Key requirements
Sex
All
Age
6+ years
Healthy volunteers?
No
Entry criteria
Patients must have been prescribed Intuniv at least once between 2016 and 2021
Doctors who have prescribed Intuniv at least once in 12 months before the start of the study